Online citations, reference lists, and bibliographies.
← Back to Search

Plasma Serotonin In Migraine And Stress.

M. Anthony, H. Hinterberger, J. Lance
Published 1967 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
IN 1961, Sicuteri, Testi, and Anselmi 1 demonstrated that the excretion in the urine of 5-hydroxyindoleacetic acid (5HIAA), the principal catabolite of serotonin (5-hydroxytryptamine, 5HT), was increased during some attacks of migraine headache. This was confirmed by Curran, Hinterberger, and Lance 2 in the majority of patients studied whereas Curzon, Theaker, and Phillips 3 were able to find such a correlation in only two out of nine migrainous subjects. Interest in the possible relationship of serotonin to the migraine syndrome had quickened following Sicuteri's preliminary trial of methysergide, a serotonin "antagonist," in the treatment of migraine. 4 The value of methysergide maleate has since been established, although the mechanism of its action is still unexplained. 5 Kimball, Friedman, and Vallejo 6 were unable to produce headache in migrainous subjects by the injection of serotonin or its precursor 5-hydroxytryptophan. Indeed they found that injection of these substances relieved spontaneous migraine headaches. These
This paper references



This paper is referenced by
10.1177/014107688107400608
Lithium in Migraine and Cluster Headache: A Review
R. Peatfield (1981)
10.1111/j.1365-2982.2004.00622.x
Comparison between partial agonist (ME3412) and antagonist (alosetron) of 5‐hydroxytryptamine 3 receptor on gastrointestinal function
K. Kawano (2005)
10.1046/j.1468-2982.2001.00157.x
Investigations into Migraine Pathogenesis: Time Course for Effects of m-CPP, BW723C86 or Glyceryl Trinitrate on Appearance of Fos-Like Immunoreactivity in Rat Trigeminal Nucleus Caudalis (TNC)
Renee S. Martin (2001)
10.1016/S0165-0173(01)00081-9
Spreading depression: a review of the clinical relevance
A. Gorji (2001)
10.1007/s00210-008-0322-7
Current and prospective pharmacological targets in relation to antimigraine action
S. Mehrotra (2008)
10.1007/978-1-4757-4577-1_10
Sandoz Lecture Migraine—A Biochemical Disorder?
J. N. Cumings (1971)
10.1161/01.STR.8.3.322
Cerebrovascular Response to Infused 5‐Hydroxytryptamine in the Baboon
A. Mendelow (1977)
10.1007/978-3-642-69841-5_2
Headaches in children.
B. Koehler (1984)
10.1016/S0140-6736(79)92692-8
NEUROTRANSMITTERS AND THE FIFTH CRANIAL NERVE: IS THERE A RELATION TO THE HEADACHE PHASE OF MIGRAINE?
MichaelA. Moskowitz (1979)
A review of the treatment of migraine.
S. Nightingale (1984)
10.1111/j.1526-4610.1994.hed3407394.x
Peripheral and Central Trigeminovascular Activation in Cat is Blocked by the Serotonin (5HT)‐I D Receptor Agonist 311C90
P. Goadsby (1994)
10.1007/s00415-006-0444-0
Increased serotonin transporter availability in the brainstem of migraineurs
S. Schuh-Hofer (2006)
10.1007/s001150050012
“Spreading depression” und Periinfarktdepolarisationen Relevante Pathomechanismen bei Migräne und Schlaganfall?
J. Roether (2000)
10.1056/NEJMRA010917
Migraine--current understanding and treatment.
P. Goadsby (2002)
10.1212/WNL.26.5.447
Migraine attacks
Y. Vardi (1976)
10.1016/0014-2999(70)90185-8
Effects of ergotamine and dihydroergotamine on uptake of 5-hydroxytryptamine in blood platelets.
O. Lingjaerde (1970)
10.1016/0014-2999(76)90264-8
Comparative effects of four migraine prophylactic drugs on an isolated extracranial artery.
J. Fozard (1976)
10.1136/pgmj.54.630.231
A basis for migraine therapy- the autonomic theory reappraised.
E. Johnson (1978)
10.1037/0033-2909.87.2.217
Migraine headache: Review of parameters, etiology, and intervention.
H. Adams (1980)
10.1111/j.1365-2710.1984.tb01088.x
THERAPEUTIC PROGRESS—REVIEW XIV
S. Nightingale (1984)
10.1177/03331024850050S3179
Positron Emission Tomographic Studies on Induced Migraine
H. Sachs (1985)
10.1016/S0140-6736(88)92122-8
POSSIBLE BENEFIT OF GR43175, A NOVEL 5-HT1-LIKE RECEPTOR AGONIST, FOR THE ACUTE TREATMENT OF SEVERE MIGRAINE
A. Doenicke (1988)
10.1046/j.1468-2982.1993.1303151.x
On Serotonin and Migraine: A Clinical and Pharmacological Review
M. Ferrari (1993)
10.1046/j.1468-2982.1982.0202083.x
Brain Hypoxia: The Turning-Point in the Genesis of the Migraine Attack?
W. Amery (1982)
10.1111/j.1526-4610.1970.hed1003093.x
THERMOGRAPHIC, HORMONAL AND CLINICAL STUDIES IN MIGRAINE
J. Lance (1970)
10.2165/00003495-197203030-00001
Current Concepts in the Pathogenesis and Interval Treatment of Migraine
M. Anthony (2012)
10.1016/0304-3959(80)90078-0
High versus low intensity acupuncture analgesia for treatment of chronic pain: Effects on platelet serotonin
W. Mao (1980)
10.1111/j.1526-4610.1994.hed3403155.x
Headache and Electroconvulsive Therapy
S. Weiner (1994)
10.1046/j.1526-4610.2000.00137.x
Reply to Spierings
P. Goadsby (2000)
10.1046/J.1468-2982.1999.019007639.X
Serotonin Infusions Inhibit Sensory Input From the Dural Vasculature
G. Lambert (1999)
10.1016/B978-012639011-7/50016-4
Influence of Serotonin on the Blood–Brain and the Blood–Spinal Cord Barriers
H. Sharma (2004)
10.1016/j.pharmthera.2010.12.001
Potential mechanisms of prospective antimigraine drugs: a focus on vascular (side) effects.
K. Chan (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar